Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 27 studies | 25% ± 8% | |
| mast cell | 24 studies | 37% ± 12% | |
| endothelial cell | 21 studies | 30% ± 12% | |
| oligodendrocyte | 16 studies | 88% ± 10% | |
| astrocyte | 15 studies | 36% ± 19% | |
| oligodendrocyte precursor cell | 15 studies | 49% ± 18% | |
| plasma cell | 12 studies | 29% ± 12% | |
| epithelial cell | 12 studies | 38% ± 17% | |
| glutamatergic neuron | 10 studies | 53% ± 26% | |
| microglial cell | 9 studies | 28% ± 15% | |
| GABAergic neuron | 8 studies | 52% ± 18% | |
| capillary endothelial cell | 7 studies | 20% ± 3% | |
| goblet cell | 7 studies | 27% ± 11% | |
| retinal cone cell | 7 studies | 58% ± 20% | |
| type I pneumocyte | 7 studies | 22% ± 4% | |
| macrophage | 7 studies | 31% ± 15% | |
| classical monocyte | 6 studies | 20% ± 5% | |
| smooth muscle cell | 6 studies | 18% ± 2% | |
| myeloid cell | 6 studies | 24% ± 6% | |
| monocyte | 6 studies | 28% ± 17% | |
| neuron | 5 studies | 41% ± 15% | |
| transit amplifying cell | 5 studies | 25% ± 8% | |
| glial cell | 5 studies | 35% ± 20% | |
| interneuron | 5 studies | 41% ± 19% | |
| hepatocyte | 5 studies | 50% ± 24% | |
| plasmablast | 4 studies | 37% ± 18% | |
| glomerular endothelial cell | 4 studies | 53% ± 2% | |
| basal cell | 4 studies | 29% ± 6% | |
| club cell | 4 studies | 21% ± 3% | |
| dendritic cell | 4 studies | 22% ± 2% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 23% ± 6% | |
| connective tissue cell | 4 studies | 27% ± 3% | |
| brush cell | 4 studies | 22% ± 4% | |
| progenitor cell | 4 studies | 25% ± 5% | |
| hematopoietic precursor cell | 3 studies | 31% ± 13% | |
| abnormal cell | 3 studies | 28% ± 11% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 66% ± 19% | |
| intestinal crypt stem cell | 3 studies | 25% ± 7% | |
| GABAergic interneuron | 3 studies | 25% ± 4% | |
| ciliated cell | 3 studies | 39% ± 13% | |
| myofibroblast cell | 3 studies | 18% ± 2% | |
| retinal rod cell | 3 studies | 37% ± 2% | |
| mesothelial cell | 3 studies | 22% ± 4% | |
| granulocyte | 3 studies | 35% ± 14% | |
| type II pneumocyte | 3 studies | 21% ± 2% | |
| ependymal cell | 3 studies | 58% ± 19% | |
| megakaryocyte | 3 studies | 52% ± 16% | |
| enteroendocrine cell | 3 studies | 29% ± 6% | |
| adventitial cell | 3 studies | 22% ± 4% | |
| alveolar macrophage | 3 studies | 24% ± 6% | |
| Schwann cell | 3 studies | 32% ± 6% | |
| endothelial cell of lymphatic vessel | 3 studies | 17% ± 1% | |
| pericyte | 3 studies | 20% ± 4% | |
| cardiac muscle cell | 3 studies | 22% ± 2% | |
| renal principal cell | 3 studies | 31% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 4032.54 | 1445 / 1445 | 100% | 68.99 | 183 / 183 |
| intestine | 100% | 5751.08 | 966 / 966 | 100% | 53.10 | 527 / 527 |
| lung | 100% | 6846.70 | 578 / 578 | 100% | 46.61 | 1153 / 1155 |
| breast | 100% | 6221.18 | 459 / 459 | 100% | 59.29 | 1116 / 1118 |
| brain | 100% | 10824.70 | 2642 / 2642 | 100% | 77.93 | 703 / 705 |
| thymus | 100% | 8290.07 | 653 / 653 | 100% | 58.78 | 603 / 605 |
| ovary | 100% | 3862.03 | 180 / 180 | 100% | 24.95 | 428 / 430 |
| stomach | 100% | 3618.75 | 358 / 359 | 100% | 50.49 | 285 / 286 |
| bladder | 100% | 4452.05 | 21 / 21 | 99% | 42.16 | 498 / 504 |
| uterus | 100% | 4848.91 | 170 / 170 | 98% | 39.85 | 451 / 459 |
| prostate | 99% | 2924.76 | 243 / 245 | 95% | 21.82 | 476 / 502 |
| pancreas | 95% | 2676.35 | 310 / 328 | 98% | 48.75 | 174 / 178 |
| skin | 100% | 9712.04 | 1808 / 1809 | 91% | 31.71 | 431 / 472 |
| kidney | 99% | 3069.85 | 88 / 89 | 87% | 21.31 | 784 / 901 |
| liver | 100% | 5314.25 | 225 / 226 | 85% | 17.62 | 347 / 406 |
| adrenal gland | 99% | 3732.21 | 255 / 258 | 62% | 10.03 | 142 / 230 |
| adipose | 100% | 5292.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 43.75 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 26.60 | 1 / 1 |
| blood vessel | 100% | 5674.12 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 97% | 2286.29 | 234 / 241 | 0% | 0 | 0 / 0 |
| heart | 85% | 2007.90 | 735 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 16.03 | 21 / 29 |
| muscle | 54% | 945.52 | 433 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 45% | 1557.42 | 415 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 19% | 2.35 | 15 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
| GO_0042426 | Biological process | choline catabolic process |
| GO_0015871 | Biological process | choline transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_0034229 | Biological process | ethanolamine transport |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0034228 | Molecular function | ethanolamine transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0015220 | Molecular function | choline transmembrane transporter activity |
| Gene name | SLC44A1 |
| Protein name | Choline transporter-like protein Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92) |
| Synonyms | CDW92 CD92 CTL1 |
| Description | FUNCTION: Choline/H+ antiporter . Also acts as a high-affinity ethanolamine/H+ antiporter, regulating the supply of extracellular ethanolamine (Etn) for the CDP-Etn pathway, redistribute intracellular Etn and balance the CDP-Cho and CDP-Etn arms of the Kennedy pathway . Involved in membrane synthesis and myelin production . . FUNCTION: Choline transporter. . FUNCTION: Choline transporter. . |
| Accessions | ENST00000374720.8 [Q8WWI5-1] A0A8V8TN05 ENST00000699290.1 Q8WWI5 ENST00000374723.5 [Q8WWI5-3] ENST00000470972.5 [Q8WWI5-1] A0A8V8TN34 ENST00000699289.1 ENST00000374724.1 [Q8WWI5-2] |